A group of scientists from the University of Kyoto is about to begin testing an experimental drug for Parkinson’s disease in humans.
Doctors from the University of Kyoto are planning to use induced pluripotent stem cells (iPS). For their development scientist Shinya Yamanaka received in 2012 the Nobel Prize in Medicine. After the introduction of cells into the brain, they can produce dopamine – a lack of this substance due to the death of neurons and causes symptoms of Parkinson’s disease. It is noted that iPS in the future will help in the treatment of other diseases.
Tests have already been conducted on monkeys. Specialists observed animals for two years. It turned out that their condition had improved. Thus, testing can be called successful.
At the moment, there is no treatment for Parkinson’s disease: patients are given drugs that alleviate the symptoms and slow the development of the ailment, but do not destroy the very cause of the illness.